Method Validation for Anticomplementary Activity of Human Immunoglobulin Drugs

M. A. Krivykh; O. G. Kornilova; N. D. Bunyatyan; E. V. Paramonova; R. A. Volkova; O. V. Fadeikina

doi:10.1007/s11094-016-1503-1

Method Validation for Anticomplementary Activity of Human Immunoglobulin Drugs

Авторлар: Krivykh M.¹, Kornilova O.¹, Bunyatyan N.¹, Paramonova E.¹, Volkova R.¹, Fadeikina O.¹
Мекемелер:
1. State Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
Шығарылым: Том 50, № 9 (2016)
Беттер: 625-629
Бөлім: Article
URL: https://journals.rcsi.science/0091-150X/article/view/244450
DOI: https://doi.org/10.1007/s11094-016-1503-1
ID: 244450

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат
Рұқсат жабық

Рұқсат берілді
Рұқсат жабық

Тек жазылушылар үшін

Аннотация
Авторлар туралы
Әдебиет тізімі
Статистика

Аннотация

Amethod for determining anticomplementary activity of human immunoglobulin (Ig) preparations for i.v. administration by complement fixation test was validated for accuracy, precision (repeatability, intralaboratory precision), limit of quantitation (LOQ), linearity, and analytical domain. The method could be used for quality assessment using the “anticomplementary activity” as part of the pharmaceutical quality examination of human Ig preparations.